Check out your Company Bowl for anonymous work chats.
Today, we're excited to share $OMDA's Q2 2025 results. Our numbers tell one story: 📈 Revenue up 49% year-over-year to $61M 👥 Member growth of 52% year-over-year to 752K members 💪 Significant progress toward profitability And our members tell an even more important one: “Omada has changed my life…True game changer! … I have lost more weight with Omada than without. But it's not just the weight loss, it is the fact I am truly healthier and happier!“ This is why we do what we do - delivering Between-Visit Care that makes a real difference in people's lives. Read more about our Q2 performance: https://lnkd.in/ekhEJS_d
We're proud that Omada Health has been named one of Fortune's Best Workplaces in the Bay Area 2025! 🎉 This recognition reflects our commitment to fostering an environment where team members feel welcomed, valued, and empowered to make a difference in healthcare. Learn more about what makes Omada a certified Great Place to Work: https://lnkd.in/eB9s_RSs hashtag#BestWorkplaces hashtag#GPTWcertified hashtag#HealthTech hashtag#BayArea
According to a recent survey of PCPs conducted by Omada, lifestyle support is a critical component of GLP-1 treatment. Read more about PCP perspectives on GLP-1 prescriptions in our survey. Read the responses: https://lnkd.in/gABuRHdV
Get to the root of food habits like over eating or over snacking 🌱 ‼️ More than 40% of American adults have obesity - with countless diet trends and calorie-counting apps, the cycle of weight loss and regain is present for many individuals. At Omada, we've always taken a different approach. Research has shown that focusing on nutrient quality rather than diet type can be key to achieving and maintaining a healthy weight. That's why our anti-diet philosophy supports lasting behavior change - whether members are on their own health journey or taking GLP-1s. Learn more about our innovative approach: https://lnkd.in/epNinXJ2
Last month our consultant relations team hosted two roundtables for over 30 benefit consultants to discuss industry topics and trends including: ⚡The next era of virtual care and how AI is making an impact ⚡The opportunity to redesign the healthcare industry to treat chronic care vs. acute care ⚡Problem solving vendor and point solution fatigue ⚡Concerns about the accessibility of GLP-1s through third parties and compounded versions ⚡How to best support members’ needs for GLP-1 treatments (persistence on medication, discontinuing treatment, supporting behavior change, etc.) ⚡The responsible use of AI We’re so grateful for the opportunity to have these insightful conversations!
Patients, providers and payers alike are investing in GLP-1 medications - but are they seeing the value they expected? One study showed that less than half of patients stayed on GLP-1s for more than three months. Factors like this mean that many who use GLP-1s for weight management may not see the results reflected in clinical trials. So, what can help patients stick with their medications and achieve the health outcomes they’re looking for? Omada’s Senior Director of Clinical and Transitional Research Sarah Linke, PhD, MPH recaps the latest GLP-1 findings from Omada Insights Lab. Watch, learn and let us know what you think! https://lnkd.in/eWFPyUCk
"To bend the curve on chronic diseases, we need to build AI systems that work for everyone, especially the communities most affected by these conditions. Chronic conditions disproportionately impact underrepresented and economically disadvantaged groups, yet these same communities often continue to face the greatest barriers to accessing and benefiting from new technologies." In our latest edition of Proof Points, Senior Manager of Clinical Quality and Health Equity, Bolanle Bukoye, digs into biases in healthcare AI, and how the industry can work toward more inclusive and transparent technologies. Read it here 👇
In a recent survey conducted by Omada, most PCPs viewed lifestyle support as a critical component of GLP-1 treatment. As a matter of fact, 87% of PCP respondents agreed or strongly agreed that GLP-1s need to be paired with diet to drive healthy weight loss, while 79% said the same about exercise. If you’d like to see what else they had to say, take a look below. Read the responses: https://lnkd.in/ehDuRgy6
Tune in to The Heart of Healthcare Podcast featuring our CEO and Co-founder Sean Duffy in conversation with hosts Halle Tecco, MPH, MBA and Michael Esquivel! 🎙️ Listen in to learn more about Sean’s perspectives on the next generation of digital health, and how we’re building a sustainable, mission-driven healthcare company. Listen to the full conversation: https://lnkd.in/dHKKhNvK
Reposted from The F Suite: Congratulations to F Suite Founding Member and CFO of Omada Health, Steve Cook, on leading Omada through its historic IPO! Steve’s path to this milestone is a masterclass in strategic finance and leadership. After senior roles at One Medical and Salesforce, Steve joined Omada in 2021 and has since played a pivotal role in scaling the business and preparing it for the public markets. Today isn’t just a milestone for Steve and Omada Health—it’s potentially a promising milestone for digital health and the future of chronic care. Omada Health’s mission is to bend the curve of chronic disease by empowering people with chronic conditions to achieve long-term health. This IPO validates not only the strength of that mission, but also the leadership that made it real—Steve being at the financial helm. Here’s to Steve and the entire Omada team as they continue to transform healthcare, one member at a time.
